Flex Pharma Presenting at Upcoming Investor Conferences in June 2016
June 03 2016 - 8:00AM
Business Wire
Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS) today announced that it will
present a corporate overview at the following upcoming investor
conferences in June:
- The Jefferies 2016 Healthcare
Conference on June 9, 2016 at 11:30 a.m. in New York, NY;
- The 36th Annual Piper Jaffray Consumer
Conference on June 15, 2016 at 10:50 a.m. in New York, NY;
- The JMP Securities 2016 Life Sciences
Conference on June 21, 2016 at 9:00 a.m. in New York, NY; and
- The 3rd Annual ROTH Healthcare Day on
June 22, 2016 in London, UK.
A live webcast of Flex Pharma’s presentations at these
conferences may be accessed in the Investor section of the
Company’s website at www.flex-pharma.com. Please log on to the Flex
Pharma website approximately 15 minutes prior to the scheduled
webcast to ensure adequate time for any software downloads that may
be required. A replay of the webcast will be available on Flex
Pharma’s website for 2 weeks following each presentation.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for nocturnal leg
cramps, cramps and spasms associated with severe neuromuscular
conditions such as MS and ALS, and exercise-associated
muscle cramps. Flex Pharma was founded by National Academy of
Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and
Bruce Bean, Ph.D., recognized leaders in the fields of ion channels
and neurobiology, along with Chair and CEO Christoph Westphal,
M.D., Ph.D.
Visit www.TeamHOTSHOT.com for updates and to learn
more about HOTSHOT™, the Company’s consumer product
which is scientifically proven to prevent and treat muscle
cramps.
HOTSHOT is a consumer product that is marketed to endurance
athletes. HOTSHOT complements the Company’s drug development
business and is not intended to diagnose, treat, cure or prevent
any disease.
Follow Flex Pharma (@flexpharma)
and HOTSHOTTM (@Team_HOTSHOT) on Twitter
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160603005169/en/
Flex Pharma, Inc.Elizabeth Woo, 617-874-1829SVP, Investor
Relations & Corporate Communicationsirdept@flex-pharma.com
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Oct 2024 to Nov 2024
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Nov 2023 to Nov 2024